Thyroid Function in patients with Ischemic Heart Diseases
Article Sidebar
Main Article Content
Abstract
The effects of thyroid hormones on the cardiovascular system are the most clinically useful and sensitive signs of thyroid dysfunction. Regarding pathophysiology, thyroid dysfunction has essential cardiovascular consequences in myocardial contractility, peripheral hemodynamics, and heart rate. The aim: To study the association of serum TSH, T4, and T3 levels on ischemic heart diseases. Patients & methods a cross sectional study was conducted in Sallah Alddin general hospital in Tikrit city – Iraq , from 1st January to 30th of June 2017. Fifty patients (34 male & 16 female ) have joined this study age (mean 58.6 ± 15.2 years), all suffering from ischemic heart diseases (myocardial infarction, angina, & congestive heart failure) & admitted to the Coronary cure unite in the hospital. Also, 50 control healthy subjects were participated in the present study, (30 males and 20 female subjects). Results anthropometric measurements for both males and females (age, weight, height BMI) show no significant differences between patients and the control, while, the BMI for female group exhibits a significant difference. Female and male lipid profile results indicate good significant differences between patients and control except for LDL result for female. Moreover, there are no significant differences for LDL and VLDL in male patients. The TSH, T3, T4, and troponin levels in both male and female patients show significant differences between them and the control groups except T3 level show no significant differences.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1]-Ghearge – Andrei Dan ( 2016) Thyroid hormone & the heart 21: 357 – 359.
[2]- Serafino Fazio, Emiliano A Palmieri,etal Effect of Thyroid hormone on the Cardiovascular system. Endojornal. Org at Penn State Hershey Gearge, Feb 23,2013.
[3]- Bahaa M. Fadeel, Samer Ellahaam, et al Hyperthyroid Heart Disease. clin.Cardio. 23, 402 – 408 (2000).
[4]- Pingitore A, Iervasi G, Barison A et al (2006) Early activation of
an altered thyroid hormone profile in asymptomatic or mildly
symptomatic idiopathic left ventricular dysfunction. J Card Fail
12:520–526.
[5]- Yeshitila Agzear, Elevated serum cardiac Troponin in non- acute coronary syndrome.J clinical Cardiol.32,1,15 – 20 (2009)
[6]- N Skeik, D Chandrakant Patel. A review of troponins in ischemic heart disease
and other conditions. Int J Angiol 2007;16(2):53-58.
[7]- Bum Ju Lee and Jong Yeol Kim. Identification of the Best Anthropometric Predictors
of Serum High- and Low-Density Lipoproteins. IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, VOL. 19, NO. 5, SEPTEMBER 2015 1747.
[8]- Margaret Smith,1 Alison Offer,1 Jieming Ma,2,3 Lijun Wang,2,3 Hongchao Pan,1 Gary Whitlock,1 Rory Collins,1 Shiru Niu2 and Richard Peto. Body mass index and mortality from ischaemic heart disease in a lean population. International Journal of Epidemiology 2006;35:141–150.
[9]- Collet TH, Gussekloo J, Bauer DC, et al; Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012; 172(10):799-809.
[10]- Serafino Fazio, Emiliano A Palmieri,etal Effect of Thyroid hormone on the Cardiovascular system. Endojornal. Org at Penn State Hershey Gearge , Feb 23,2013.
[11]- Rajeeb Kalita, Vivek Jain. “Alterations in Serum Lipid Prole in Ischemic Heart Disease: A
Hospital Based Study”.global jornal for research analysis volume: 3 | Issue: 11 | November 2014. ISSN No 2277 – 8179.
[12]- Klein I, Ojamaa K. Mechanism of disease: thyroid hormone and the cardiovascular system. N Engl J Med 344: 501–509, 2001.
[13]- Grais IM, Sowers JR. Thyroid and the heart. Am J Med. 2014;127(8):691-698.
[14]- Rucsandra Dănciulescu Miulescu, Marius Cristian Neamţu, enisa Margină, Cătălina Poiană, Diana Loreta Păun. Associations between thyroid dysfunction and chronic kidney disease. Rom J Diabetes Nutr Metab Dis. 2014; 21(1): 37-42.
[15]- Rodondi N, den Elzen WP, Bauer DC, et al; Thyroid Studies Collaboration.
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010; 304(12): 1365-1374.
[16]- Gencer B, Collet TH, Virgini V, et al; Thyroid Studies Collabora - tion. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from
6 prospec-tive cohorts. Circulation. 2012; 126(9): 1040-1049.
[17]- Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiff-ness: a systematic review and meta-analysis. J Am Coll Car-diol. 2010; 55(13): 1318-1327.
[18]- Nedaa Skeik, Deevia Chandrakant Patel. A review of troponins in ischemic heart disease and other conditions. Int J Angiol Vol 16 No 2 Summer 2007.